U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375498) titled 'Phase 1 Clinical Study of the Safety and Pharmacokinetics of Rescue Liposome in Healthy Adult Participants' on Jan. 13.
Brief Summary: This is a Phase 1 study to assess the safety and tolerability of the liposomal product in healthy participants.
Study Start Date: Aug. 20, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Overdose Antidote
Intervention:
DRUG: liposome dispersion
liposome rescue
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Cristalia Produtos Quimicos Farmaceuticos Ltda.
Disclaimer: Curated by HT Syndication....